Food and Drug Administration approved Foundayo (orforglipron) for adults with obesity, or for adults who are overweight and have at least one weight-related medical condition such as high blood pressure, type 2 diabetes, or high cholesterol
1 Its primary purpose is to lower blood sugar, which is determined using the hemoglobin A1C test, which determines average blood sugar levels over a three-month period
They're your cat and you love them
Strict dieting is not required, Yes, GLP-1 medications were originally developed for diabetes management and can improve insulin sensitivity while supporting weight loss
For every pound of weight lost, patients experience a substantial decrease with each step in the force placed on weight-bearing joints such as the knees and hips
These mechanisms make semaglutide effective for both glycemic control in type 2 diabetes and weight management in obesity